Upregulation of IL-1 Receptor Antagonist in a Mouse Model of Migraine
AbstractMigraine is a disorder characterized by attacks of monolateral headaches, often accompanied by nausea, vomiting, and photophobia. Around 30% of patients also report aura symptoms. The cause of the aura is believed to be related to the cortical spreading depression (CSD), a wave of neuronal and glial depolarization originating in the occipital cortex, followed by temporary neuronal silencing. During a migraine attack, increased expression of inflammatory mediators, along with a decrease in the expression of anti-inflammatory genes, have been observed. The aim of this study was to evaluate the expression of inflammatory genes, in particular that of IL-1 receptor antagonist (IL-1RN), following CSD in a mouse model of familial hemiplegic migraine type 1 (FHM-1). We show here that the expression of IL-1RN was upregulated after the CSD, suggesting a possible attempt to modulate the inflammatory response. This study allows researchers to better understand the development of the disease and aids in the search for new therapeutic strategies in migraine. View Full-Text
- Supplementary File 1:
ZIP-Document (ZIP, 220 KB)
Share & Cite This Article
Lombardo, S.D.; Mazzon, E.; Basile, M.S.; Cavalli, E.; Bramanti, P.; Nania, R.; Fagone, P.; Nicoletti, F.; Petralia, M.C. Upregulation of IL-1 Receptor Antagonist in a Mouse Model of Migraine. Brain Sci. 2019, 9, 172.
Lombardo SD, Mazzon E, Basile MS, Cavalli E, Bramanti P, Nania R, Fagone P, Nicoletti F, Petralia MC. Upregulation of IL-1 Receptor Antagonist in a Mouse Model of Migraine. Brain Sciences. 2019; 9(7):172.Chicago/Turabian Style
Lombardo, Salvo D.; Mazzon, Emanuela; Basile, Maria S.; Cavalli, Eugenio; Bramanti, Placido; Nania, Riccardo; Fagone, Paolo; Nicoletti, Ferdinando; Petralia, Maria C. 2019. "Upregulation of IL-1 Receptor Antagonist in a Mouse Model of Migraine." Brain Sci. 9, no. 7: 172.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.